These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36308580)

  • 1. Evidence for Implementation: Management of TB in HIV and Pregnancy.
    Jones AJ; Mathad JS; Dooley KE; Eke AC
    Curr HIV/AIDS Rep; 2022 Dec; 19(6):455-470. PubMed ID: 36308580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
    van der Laan LE; Garcia-Prats AJ; Schaaf HS; Tikiso T; Wiesner L; de Kock M; Winckler J; Norman J; McIlleron H; Denti P; Hesseling AC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
    Chirehwa MT; McIlleron H; Rustomjee R; Mthiyane T; Onyebujoh P; Smith P; Denti P
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa.
    Mokhele I; Jinga N; Berhanu R; Dlamini T; Long L; Evans D
    BMC Pregnancy Childbirth; 2021 Jun; 21(1):453. PubMed ID: 34182944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis (TB) in pregnancy - A review.
    Orazulike N; Sharma JB; Sharma S; Umeora OUJ
    Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():167-177. PubMed ID: 33684671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s.
    Van Schalkwyk M; Bekker A; Decloedt E; Wang J; Theron GB; Cotton MF; Eke AC; Cressey TR; Shapiro DE; Bacon K; Knowles K; George K; Browning R; Chakhtoura N; Rungruengthanakit K; Wiesner L; Capparelli EV; Stek AM; Mirochnick M; Best BM;
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0073723. PubMed ID: 37882552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis in pregnancy: a review.
    Loto OM; Awowole I
    J Pregnancy; 2012; 2012():379271. PubMed ID: 22132339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in pregnancy.
    Hui SYA; Lao TT
    Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt A):34-44. PubMed ID: 36002371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
    Marks SM; Mase SR; Morris SB
    Clin Infect Dis; 2017 Jun; 64(12):1670-1677. PubMed ID: 28329197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV.
    Abdelwahab MT; Leisegang R; Dooley KE; Mathad JS; Wiesner L; McIlleron H; Martinson N; Waja Z; Letutu M; Chaisson RE; Denti P
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa.
    Khan M; Pillay T; Moodley J; Ramjee A; Padayatchi N
    Int J Tuberc Lung Dis; 2007 Jun; 11(6):706-8. PubMed ID: 17519106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.
    Regazzi M; Carvalho AC; Villani P; Matteelli A
    Clin Pharmacokinet; 2014 Jun; 53(6):489-507. PubMed ID: 24777631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.
    Arentz M; Pavlinac P; Kimerling ME; Horne DJ; Falzon D; Schünemann HJ; Royce S; Dheda K; Walson JL;
    PLoS One; 2012; 7(11):e47370. PubMed ID: 23144818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings.
    Wilson JW; Nilsen DM; Marks SM
    Ann Am Thorac Soc; 2020 Jan; 17(1):16-23. PubMed ID: 31365831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.